{"name":"Laboratoire Innotech International","slug":"laboratoire-innotech-international","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"POLYGYNAX®","genericName":"POLYGYNAX®","slug":"polygynax","indication":"Vaginal infections caused by susceptible bacteria and Candida species","status":"phase_3"},{"name":"GYNODAKTARIN®","genericName":"GYNODAKTARIN®","slug":"gynodaktarin","indication":"Vaginal candidiasis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Polygynax combinaison of polymyxin, Neomycin and Nystatin","genericName":"Polygynax combinaison of polymyxin, Neomycin and Nystatin","slug":"polygynax-combinaison-of-polymyxin-neomycin-and-nystatin","indication":"Other","status":"marketed"},{"name":"Benzalkonium Chloride Spermicide Cream","genericName":"Benzalkonium Chloride Spermicide Cream","slug":"benzalkonium-chloride-spermicide-cream","indication":"Contraception / prevention of pregnancy","status":"marketed"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"TOT'HEMA","genericName":"TOT'HEMA","slug":"tot-hema","indication":"Iron deficiency anemia","status":"marketed"}]}],"pipeline":[{"name":"POLYGYNAX®","genericName":"POLYGYNAX®","slug":"polygynax","phase":"phase_3","mechanism":"POLYGYNAX is a vaginal capsule containing a combination of antibiotics and antifungal agents that eliminates pathogenic bacteria and fungi in the vaginal tract.","indications":["Vaginal infections caused by susceptible bacteria and Candida species","Non-specific vaginitis"],"catalyst":""},{"name":"Polygynax combinaison of polymyxin, Neomycin and Nystatin","genericName":"Polygynax combinaison of polymyxin, Neomycin and Nystatin","slug":"polygynax-combinaison-of-polymyxin-neomycin-and-nystatin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Benzalkonium Chloride Spermicide Cream","genericName":"Benzalkonium Chloride Spermicide Cream","slug":"benzalkonium-chloride-spermicide-cream","phase":"marketed","mechanism":"Benzalkonium chloride is a cationic surfactant that disrupts sperm cell membranes, immobilizing and killing sperm to prevent fertilization.","indications":["Contraception / prevention of pregnancy"],"catalyst":""},{"name":"GYNODAKTARIN®","genericName":"GYNODAKTARIN®","slug":"gynodaktarin","phase":"phase_3","mechanism":"GYNODAKTARIN is an antifungal agent that disrupts fungal cell membrane integrity by inhibiting ergosterol synthesis.","indications":["Vaginal candidiasis","Dermatophyte infections (tinea pedis, tinea corporis, tinea cruris)"],"catalyst":""},{"name":"TOT'HEMA","genericName":"TOT'HEMA","slug":"tot-hema","phase":"marketed","mechanism":"TOT'HEMA is an oral iron supplement that replenishes iron stores to treat iron deficiency anemia.","indications":["Iron deficiency anemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUkV4aURYVUx3R01UWmpJdlpuZWhQR0ZISzBoVFZ5cVdlS0tsMlVUb3RNdFVlQmNHVmRQdlE3dENYcGo0UTBFLVJDOVN0Rm9hUkNNaFluLTVWa1lCUHJ2emZRajI2bUIyUlpUSXZSNXlJYzFqaWVYWVltenlHdWlWZllDSE91czA1OEdkaFdWenltVGNPRTR1U1Zkb29qT3VqeWfSAaQBQVVfeXFMT0xsSjVYZGtxV0ZDdjZPQTBacVZHeXRubUQyZjVJNS1SMlBQcC1PdnRNZTRheW9SVDN1ZGZNVWR4M01uNDBrOUdFUm9iLTNrZUJObWh4bjB6VXJFbWdkdU85WGhHcHhINlBrOFp4TFFkNUZDdWFYNWJpQzVqeWRQejg1SzlwTnZ5TEtKTV9XRVYyXzNJQTB0NEV4VkhTYXhrTDUtX2c?oc=5","date":"2023-10-04","type":"pipeline","source":"Radio Free Europe/Radio Liberty","summary":"How The Tajik President's Daughter Built A Pharma Empire (With A Little Help From Dad) - Radio Free Europe/Radio Liberty","headline":"How The Tajik President's Daughter Built A Pharma Empire (With A Little Help From Dad) - Radio Free Europe/Radio Liberty","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_3":2,"marketed":3},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}